Micronoma
Financing Round
- Seed/Pre-A
Round Led by Symbiosis
Micronoma was founded in 2019 by leaders in microbiome research with the goal of revolutionizing cancer diagnostics. Micronoma is the first cancer detection company using circulating microbiome signatures to diagnose cancer at an early stage with minimally invasive blood tests. By ensuring that patients’ needs are identified at the earliest stage, and enabling personalized treatment, Micronoma hopes to help cancer patients live longer, healthier lives.
